CellTrend diagnostic test

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Revision as of 22:13, January 24, 2017 by Kmdenmark (talk | contribs) (expanded)

The CellTrend Diagnostic Test is a commercial ME/CFS diagnostic assay created by CellTrend and Professor Doctor Carmen Scheibenbogen. The test and its cost have been criticised by patients.[1]

Auto-antibodies[edit | edit source]

Cell-Trend bases its test on the theory that a subset of 20-30% of all patients suffering from ME/CFS have developed elevated levels of three auto-antibodies, i.e., auto-antibodies against the b2-adrenergic receptor, auto-antibodies against the muscarinic cholinergic receptor 3 (M3) and auto-antibodies against the muscarinic cholinergic receptor 4 (M4).[2]

Notable studies[edit | edit source]

  • 2016, Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome[3]

References[edit | edit source]

  1. CellTrend test for ME/CFS (Prof. Dr. Carmen Scheibenbogen, University Hospital Charite Berlin, etc.)
  2. http://www.celltrend.de/cfs-diagnostics.html
  3. Loebel, M; Grabowski, P; Heidecke, H; Bauer, S; Hanitsch, LG; Wittke, K; Meisel, C; Reinke, P; Volk, H; Fluge, Ø; Mella, O; Scheibenbogen, C (2016), "Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome", Brain, behavior, and immunity, 52: 32-39, doi:10.1016/j.bbi.2015.09.013